Deciphera Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:DCPH Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
16 Feb 24	SellUS$35,405	Jama Pitman	Individual	2,267	US$15.62
16 Feb 24	SellUS$35,405	Daniel Martin	Individual	2,267	US$15.62
16 Feb 24	SellUS$47,009	Thomas Kelly	Individual	3,010	US$15.62
16 Feb 24	SellUS$40,840	Matthew Sherman	Individual	2,615	US$15.62
16 Jan 24	SellUS$23,499	Daniel Martin	Individual	1,624	US$14.47
16 Jan 24	SellUS$35,234	Thomas Kelly	Individual	2,435	US$14.47
16 Jan 24	SellUS$23,499	Jama Pitman	Individual	1,624	US$14.47
16 Jan 24	SellUS$35,234	Matthew Sherman	Individual	2,435	US$14.47
13 Dec 23	SellUS$42,905	Matthew Sherman	Individual	2,792	US$15.37
13 Dec 23	SellUS$26,539	Daniel Martin	Individual	1,727	US$15.37
13 Dec 23	SellUS$42,905	Thomas Kelly	Individual	2,792	US$15.37
13 Dec 23	SellUS$25,540	Jama Pitman	Individual	1,662	US$15.37
13 Dec 23	SellUS$471,217	Steven Hoerter	Individual	30,664	US$15.37
30 Nov 23	SellUS$223,755	Daniel Martin	Individual	17,801	US$12.57

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of DCPH?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	1,597	0.00185%
Individual Insiders	615,193	0.711%
General Public	1,905,923	2.2%
Hedge Funds	16,323,913	18.9%
VC/PE Firms	23,107,844	26.7%
Institutions	44,521,502	51.5%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 10.1%.

Top Shareholders

Top 25 shareholders own 82.75% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
26.7%	Brightstar Associates, LLC	23,107,844	US$591.3m	0.21%	no data
6.93%	BlackRock, Inc.	5,994,276	US$153.4m	0.3%	no data
6.82%	Armistice Capital LLC	5,900,000	US$151.0m	13.5%	4.18%
6.12%	Redmile Group, LLC	5,296,643	US$135.5m	10.3%	5.46%
5.93%	Deerfield Management Company, L.P. Series C	5,127,270	US$131.2m	-11.4%	2.38%
5.28%	The Vanguard Group, Inc.	4,565,044	US$116.8m	3.71%	no data
3.58%	State Street Global Advisors, Inc.	3,098,806	US$79.3m	25.4%	no data
2.16%	Emerald Advisers, LLC	1,869,273	US$47.8m	56.1%	1.08%
1.86%	Dimensional Fund Advisors LP	1,606,132	US$41.1m	2.85%	0.01%
1.73%	Polar Capital Holdings Plc	1,500,000	US$38.4m	-18.9%	0.15%
1.69%	Goldman Sachs Group, Investment Banking and Securities Investments	1,463,417	US$37.4m	-19.5%	0.02%
1.68%	Frazier Life Sciences Management, LP	1,455,837	US$37.3m	42.5%	1.79%
1.65%	Teachers Insurance and Annuity Association-College Retirement Equities Fund	1,422,770	US$36.4m	0.89%	0.01%
1.53%	Morgan Stanley, Investment Banking and Brokerage Investments	1,321,377	US$33.8m	-37%	no data
1.45%	Geode Capital Management, LLC	1,254,317	US$32.1m	2.7%	no data
0.95%	Jefferies Financial Group Inc.,Asset Management Arm	822,515	US$21.0m	-10.4%	0.51%
0.94%	Assenagon Asset Management S.A.	809,923	US$20.7m	0%	0.04%
0.92%	Millennium Management LLC	797,100	US$20.4m	22.2%	0.02%
0.84%	Parkman Healthcare Partners LLC	729,230	US$18.7m	30%	2.44%
0.7%	Braidwell LP	609,643	US$15.6m	-47.9%	0.96%
0.69%	Tang Capital Management, LLC	600,000	US$15.4m	0%	1.86%
0.67%	New Leaf Venture Partners, LLC	576,975	US$14.8m	0%	15.11%
0.65%	UBS Asset Management AG	564,978	US$14.5m	7.34%	no data
0.61%	Charles Schwab Investment Management, Inc.	531,475	US$13.6m	3.14%	no data
0.61%	Renaissance Technologies LLC	530,200	US$13.6m	21.2%	0.02%